[Chronic heart failure: how can the family doctor put current guidelines into practice?].
Finsterer
S
S
Kardiologische Praxis und Praxisklinik München.
Weyerbrock
S
S
Basler
M
M
Mühling
H
H
Silber
S
S
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D017147:Defibrillators, Implantable; D004232:Diuretics / Q000627:therapeutic use; D005194:Family Practice; D019983:Guideline Adherence; D006333:Heart Failure / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D016027:Heart Transplantation; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D010138:Pacemaker, Artificial; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D014665:Vasodilator Agents